SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 46.75

Change

+0.08 (+0.17)%

Market Cap

N/A

Volume

3.20M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-03 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

-2.03 (-0.46%)

USD 128.84B
REGN Regeneron Pharmaceuticals Inc

-1.86 (-0.38%)

USD 65.38B
ARGX argenx NV ADR

+7.09 (+1.24%)

USD 34.54B
ALNY Alnylam Pharmaceuticals Inc

+2.69 (+0.88%)

USD 32.75B
ONC BeiGene, Ltd.

-1.27 (-0.49%)

USD 27.70B
RPRX Royalty Pharma Plc

+0.31 (+0.93%)

USD 18.35B
SMMT Summit Therapeutics PLC

+0.17 (+0.87%)

USD 13.53B
INSM Insmed Inc

-0.95 (-1.29%)

USD 11.84B
INCY Incyte Corporation

-0.18 (-0.27%)

USD 11.42B
BMRN Biomarin Pharmaceutical Inc

-0.84 (-1.50%)

USD 11.29B

ETFs Containing SWTX

SAFE:CA Global X Equal Weight Can.. 27.62 % 0.00 %

-0.04 (0.12%)

CAD 2.65M
HFIN:CA Hamilton Enhanced Canadia.. 11.55 % 0.00 %

N/A

CAD 0.19B
HFN:CA Hamilton Canadian Financi.. 9.51 % 0.00 %

+0.02 (+0.12%)

CAD 0.01B
XDNA:CA iShares Genomics Immunolo.. 4.82 % 0.00 %

-0.12 (0.12%)

CAD 4.62M
TQCD:CA TD Q Canadian Dividend ET.. 3.80 % 0.00 %

+0.03 (+0.12%)

CAD 0.38B
HLIF:CA Harvest Canadian Equity I.. 3.47 % 0.00 %

N/A

CAD 0.12B
CDEF:CA Manulife Smart Defensive .. 3.00 % 0.00 %

N/A

CAD 1.45M
BBP Virtus LifeSci Biotech Pr.. 2.24 % 0.79 %

+0.20 (+0.12%)

USD 0.02B
CEW:CA iShares Equal Weight Banc.. 0.00 % 0.60 %

+0.04 (+0.12%)

CAD 0.23B
DXM:CA 0.00 % 0.67 %

N/A

N/A
FIE:CA iShares Canadian Financia.. 0.00 % 0.97 %

+0.01 (+0.12%)

CAD 1.06B
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

-0.14 (0.12%)

CAD 0.09B
HAL:CA Global X Active Canadian .. 0.00 % 0.78 %

+0.01 (+0.12%)

CAD 0.12B
HEF:CA 0.00 % 0.83 %

N/A

N/A
HPR:CA Global X Active Preferred.. 0.00 % 0.63 %

+0.02 (+0.12%)

CAD 0.95B
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

+0.03 (+0.12%)

CAD 0.08B
IDNA iShares Genomics Immunolo.. 0.00 % 0.00 %

-0.11 (0.12%)

USD 0.10B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

-0.01 (0.12%)

N/A
XMD:CA iShares S&P/TSX Completio.. 0.00 % 0.61 %

+0.22 (+0.12%)

CAD 0.28B
XMV:CA iShares MSCI Canada Minim.. 0.00 % 0.33 %

-0.19 (0.12%)

CAD 0.29B
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

+0.01 (+0.12%)

CAD 0.40B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

-0.04 (0.12%)

N/A
CDIV:CA Manulife Smart Dividend E.. 0.00 % 0.00 %

N/A

CAD 0.64B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.39% 84% B 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.39% 84% B 89% A-
Trailing 12 Months  
Capital Gain 20.15% 79% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.15% 79% B- 75% C
Trailing 5 Years  
Capital Gain 24.40% 81% B- 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.40% 81% B- 53% F
Average Annual (5 Year Horizon)  
Capital Gain 2.90% 57% F 52% F
Dividend Return 2.90% 57% F 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 49.07% 63% D 36% F
Risk Adjusted Return 5.91% 58% F 43% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector